IMNM – immunome, inc. (US:NASDAQ)
Stock Stats
News
Immunome (IMNM) Is Up 11.7% After Phase 3 Varegacestat Success - Has The Bull Case Changed? [Yahoo! Finance]
Assessing Immunome (IMNM) Valuation After Recent Share Price Momentum And Conflicting P/B And DCF Signals [Yahoo! Finance]
Is Immunome, Inc. (IMNM) The Best Booming Stock To Buy Right Now? [Yahoo! Finance]
Immunome (NASDAQ:IMNM) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $31.00 price target on the stock.
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Form 4 Immunome Inc. For: Dec 30 Filed by: SIEGALL CLAY B
Form 4 Immunome Inc. For: Dec 22 Filed by: Barchas Isaac
Form SCHEDULE 13D/A Immunome Inc. Filed by: Enavate Sciences GP, LLC
Form 4 Immunome Inc. For: Dec 19 Filed by: Higgins Jack
Form 4 Immunome Inc. For: Dec 19 Filed by: SIEGALL CLAY B
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.